Skip to main content
OpenTrials

Clinical trial condition

Lymphocytic Leukemia, Chronic

Explore clinical trials studying Lymphocytic Leukemia, Chronic. Study availability and eligibility vary by location and protocol.

28 public trials 1 recruiting study
Refine in advanced search Browse all conditions

Lymphocytic Leukemia, Chronic trial results

Completed

Comparison of the Treatments of Obinutuzumab + Venetoclax Versus Obinutuzumab + Chlorambucil in Patients With Chronic Lymphocytic Leukemia

NCT02242942

Conditions
Chronic Disease, Disease Attributes, Hematologic Diseases, +14 more
Locations
  • Banner MD Anderson Cancer Center Gilbert, Arizona, United States
  • City of Hope Duarte, California, United States
  • UC San Diego Health System La Jolla, California, United States
  • Moffitt Cancer Center Tampa, Florida, United States
View all 122 locations
View Trial Details
Completed

A Safety, Efficacy and Pharmacokinetic Study of BTCT4465A (Mosunetuzumab) as a Single Agent and Combined With Atezolizumab in Non-Hodgkin's Lymphoma (NHL) and Chronic Lymphocytic Leukemia (CLL)

NCT02500407

Conditions
Chronic Disease, Disease Attributes, Hematologic Diseases, +17 more
Locations
  • University of California San Diego Moores Cancer Center La Jolla, California, United States
  • Sansum Medical Clinic, Inc. Santa Barbara, California, United States
  • Rocky Mountain Cancer Center Denver, Colorado, United States
  • Yale University School Of Medicine New Haven, Connecticut, United States
View all 35 locations
View Trial Details
Completed

A Study of Venetoclax in Combination With Obinutuzumab in Participants With Chronic Lymphocytic Leukemia

NCT01685892

Conditions
Chronic Disease, Disease Attributes, Hematologic Diseases, +14 more
Locations
  • UCSD Moores Cancer Center La Jolla, California, United States
  • Colorado Blood Cancer Institute (CBCI) at Presbyterian/ St. Luke's Medical Center Denver, Colorado, United States
  • Weill Cornell Medical College-New York Presbyterian Hospital New York, United States
  • Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States
View Trial Details
Completed

A Study to Compare Subcutaneous Versus Intravenous MabThera (Rituximab) in Combination With Chemotherapy in Patients With Chronic Lymphocytic Leukemia

NCT01292603

Conditions
Chronic Disease, Disease Attributes, Hematologic Diseases, +14 more
Locations
  • Fundaleu; Haematology Buenos Aires, Argentina
  • Cemic; Haematology Buenos Aires, Argentina
  • HOSPITAL PRIVADO - CENTRO MEDICO DE CÓRDOBA; Dpto Oncología Córdoba, Argentina
  • St George Hospital; Department of Haematology Kogarah, New South Wales, Australia
View all 84 locations
View Trial Details
Completed

CLL11: A Study of Rituximab With Chlorambucil or Chlorambucil Alone in Patients With Previously Untreated Chronic Lymphocytic Leukemia (Stage 1b)

NCT01998880

Conditions
Chronic Disease, Disease Attributes, Hematologic Diseases, +14 more
Locations
  • San Diego, California, United States
  • Chicago, Illinois, United States
  • Baltimore, Maryland, United States
  • Green Bay, Wisconsin, United States
View all 261 locations
View Trial Details
Completed

CLL11: A Study of Obinutuzumab (RO5072759 [GA101]) With Chlorambucil in Patients With Previously Untreated Chronic Lymphocytic Leukemia (Stage 1a)

NCT01010061

Conditions
Chronic Disease, Disease Attributes, Hematologic Diseases, +14 more
Locations
  • San Diego, California, United States
  • Chicago, Illinois, United States
  • Baltimore, Maryland, United States
  • Green Bay, Wisconsin, United States
View all 261 locations
View Trial Details
Completed

CLL11: A Study of Obinutuzumab (RO5072759 [GA101]) With Chlorambucil in Patients With Previously Untreated Chronic Lymphocytic Leukemia (Stage 2)

NCT02053610

Conditions
Chronic Disease, Disease Attributes, Hematologic Diseases, +14 more
Locations
  • San Diego, California, United States
  • Chicago, Illinois, United States
  • Baltimore, Maryland, United States
  • Green Bay, Wisconsin, United States
View all 261 locations
View Trial Details
Completed

A Study to Assess the Effect of Maintenance Treatment With Rituximab Versus No Treatment in Participants With Progressive B-Cell Chronic Lymphocytic Leukemia (CLL)

NCT00718549

Conditions
Chronic Disease, Disease Attributes, Hematologic Diseases, +14 more
Locations
  • City Clinical Hospital #9 Minsk, Belarus
  • Medical University, Independent Public Clinical Hospital; Dept. of Hematology, SPSK Bialystok, Poland
  • Szpital Uniwersytecki W Krakowie; Klinika Hematologii Krakow, Poland
  • Medical University School; Dept. of Haematology Lodz, Poland
View Trial Details

Related conditions